The agreement will allow materials science researchers to benefit from solutions combining HORIBA’s advances in AFM instrumentation with Qnami’s innovation in quantum sensing
LC 300 platform and SimplicityChrom software offers improved workflows, intuitive user interface and 21 CFR Part 11 compliance
The collaboration aims to secure manufacturing and testing capacity in the next phase of the pandemic
Observations of rapid recovery on chest x-rays noted and no drug-related Serious Adverse Events reported
The new lots further enhance Lonza’s renowned human primary cell offerings as it looks to meet growing market demand for deeper cell characterization
The new HyPix-Arc 100 curved detector is based on direct X-ray detection technology, with a higher 20 range compared to a flat detector
Watch this on-demand webinar to learn about the pathogenicity and transmission of Salmonella
As SARS-CoV-2 vaccines become available, Siemens Healthineers is ready with fully automated antibody tests that can be used to help inform whether broad vaccination programs are working
Watch this on-demand webinar to discover the challenges associated with analyzing AAV samples, and learn how LC and LC-MS workflows can help solve these setbacks
In this webinar Aaron Hineman, PerkinElmer, will review a total ICP-MS solution for your pharmaceutical impurity testing needs
Test adds to QIAGEN’s growing portfolio of PCR testing solutions for COVID-19 testing
Join scientists from across the globe to explore the latest developments in biopharma, from new research techniques to cutting-edge technologies and resources to advance your work
Watch this on-demand webinar to find out how to use the dragonfly discovery to set up robust high-throughput assays quickly
QIAreach SARS-CoV-2 Antigen Test is an important step towards decentralized mass screening by processing samples in 2–15 minutes
Non-invasive sample collection and batch processing to test symptomatic and asymptomatic individuals
Internationally renowned Hans Clevers Lab reports using AMSBIO’s CELLBANKER reagent to freeze down their organoids ahead of the COVID-19 spring lockdown
Phase 3 part of clinical trial to enrol over 30,000 volunteers worldwide
